Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles (Q94571902)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 May 2020

Language	Label	Description	Also known as
English	Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles	scientific article published on 09 May 2020

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

retracted paper

1 reference

Retraction Watch

29 December 2023

https://doi.org/10.1007/s00436-022-07440-8

Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Acanthamoeba castellanii

object named as

Acanthamoeba castellanii

1 reference

based on heuristic

inferred from title

Naveed Ahmed Khan

6

object named as

Naveed Ahmed Khan

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

author name string

Areeba Anwar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Yim Pei Yi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Itrat Fatima

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Khalid Mohammed Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Ruqaiyyah Siddiqui

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Ayaz Anwar

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

publication date

9 May 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Galactose as novel target against Acanthamoeba cysts

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Antimicrobial properties of a novel silver-silica nanocomposite material

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Brief report: successful treatment of disseminated acanthamoeba infection in an immunocompromised patient

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492)

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Cytomorphological changes and susceptibility of clinical isolates of Acanthamoeba spp. to heterocyclic alkylphosphocholines

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

The cell cycle and induced amitosis in Acanthamoeba

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Acanthamoeba keratitis as a complication of orthokeratology

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Acanthamoeba keratitis: diagnosis and treatment update 2009.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Use of in vitro assays to determine effects of human serum on biological characteristics of Acanthamoeba castellanii

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Acanthamoeba: biology and increasing importance in human health

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Evaluation of in vitro effect of selected contact lens solutions conjugated with nanoparticles in terms of preventive approach to public health risk generated by Acanthamoeba strains

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Cellulose fibrils formation and organisation of cytoskeleton during encystment are essential for Acanthamoeba cyst wall architecture

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

The use of miltefosine in the management of refractory Acanthamoeba keratitis.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Differentiation in Acanthamoeba castellanii

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

An Unusual Cause of Central Nervous System Infection During Acute Myeloid Leukemia Induction Chemotherapy: Acanthamoeba Brain Abscess

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Is metronidazole carcinogenic?

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Synthesis of structural analogues of hexadecylphosphocholine and their antineoplastic, antimicrobial and amoebicidal activity

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

The Rise and Fall of Oral Ketoconazole

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Synthesis of 3-tetrazolylmethyl-4H-chromen-4-ones via Ugi-azide and biological evaluation against Entamoeba histolytica, Giardia lamblia and Trichomona vaginalis

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51)

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Photochemotherapeutic strategy against Acanthamoeba infections.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Biology and pathogenesis of Acanthamoeba

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Lipids of pathogenic fungi

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Coinfection with Acanthamoeba and Pseudomonas in contact lens-associated keratitis

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Antibacterial Activities of Azole Complexes Combined with Silver Nanoparticles.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Current applications of nanoparticles in infectious diseases.

1 reference

30 June 2024

https://opencitations.net/index/api/v1/references/10.1007/S00436-020-06694-4

Identifiers

10.1007/S00436-020-06694-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32385711%20AND%20SRC:MED&resulttype=core&format=json

16 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q94571902&oldid=2192389385"